#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Breast cancer metastatic Non-small cell lung cancer metastatic Type 2 diabetes mellitus More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Bone marrow disorder Metachromatic leukodystrophy Myxofibrosarcoma Idiopathic pulmonary fibrosis Raynaud's phenomenon Glycogen storage disease type I Neutropenia Acute leukaemia ROHHAD syndrome Hepatobiliary cancer Transferrin decreased Obliterative bronchiolitis Adenoid cystic carcinoma Angiosarcoma metastatic Acute graft versus host disease in liver More trials…

    Learn about Rare Diseases

    Inclusion body myositis – Life with Disease Primary hyperoxaluria – Trials in Disease Mucous membrane pemphigoid – Treatment Medulloblastoma recurrent – Treatment Pleural mesothelioma malignant – Trials in Disease Primary mediastinal large B-cell lymphoma – Trials in Disease Angiosarcoma non-metastatic – Diagnostics Arterial tortuosity syndrome – Basic Information Langerhans’ cell histiocytosis – Treatment Haemophilia A with anti factor VIII – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    BENZYDAMINE HYDROCHLORIDE Valiltramiprosate Gsk4527226 AP31969 SULFATE Olanzapine Abc-16F-116 Azd7798 Asundexian Rosuvastatin Rtx001 COBALAMIN Tyra-300-B01 Ondansetron SODIUM SULFIDE NONAHYDRATE Lenzumestrocel Ropivacaine Redasemtide Foscarnet Sodium Hexahydrate Fitusiran Magnesium Chloride More therapies…

    Learn about Your Condition

    Anxiety Diabetic foot infection Small intestine carcinoma Anal cancer Intracranial calcification Hot flush Peritoneal sarcoma Metabolic syndrome Spinal muscular atrophy Burning mouth syndrome Chronic spontaneous urticaria Neoplasm Colitis Kaposi's sarcoma Langerhans cell sarcoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Respiratory Tract Diseases

  • Study of Brenipatide (LY3537031) in Adults with Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)

    Recruiting

    2 1
    Investigated Diseases:
    • Chronic obstructive pulmonary disease
    Investigated Drugs:
    • LY3537031
    Austria Czechia Denmark France Germany Hungary +2

  • A Study of Brenipatide Compared to Placebo for Adults with Uncontrolled Moderate to Severe Asthma

    Recruiting

    2 1
    Investigated Drugs:
    • LY3537031
    France Germany The Netherlands Poland

  • A Study of Depemokimab Compared to Placebo in Adults with Chronic Obstructive Pulmonary Disease and Type 2 Inflammation

    Recruiting

    3 1 1
    Investigated Drugs:
    • Depemokimab
    • Salbutamol Sulfate
    Austria Bulgaria Czechia Germany Greece Italy +2

  • Study of Baricitinib in Children Aged 1 to 17 Hospitalized with COVID-19

    Recruiting

    3 1 1
    Investigated Diseases:
    • COVID-19
    Investigated Drugs:
    • Baricitinib
    Belgium Spain

  • Efficacy and safety of human alpha1‑proteinase inhibitor weekly infusions in adults with alpha1 antitrypsin deficiency–related emphysema

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Human Alpha1-Proteinase Inhibitor
    Denmark

  • Tezepelumab Effects on TSLP Protein Induction in Adults with Severe Asthma, With and Without Chronic Rhinosinusitis

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Tezepelumab
    Denmark
1 2 3 … 90
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!